N@N

Clinical Data To Present at Piper Jaffray 20th Annual Health Care Conference

^{Published on 2008-12-01 08:25:36 - Market Wire}
 

NEWTON, Mass.--([ BUSINESS WIRE ])--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a Company overview at the Piper Jaffray 20^th Annual Health Care Conference in New York. Clinical Data's presentation will take place on December 3, 2008 at 2:30 p.m. EST.

The live audio and archived webcast of the Company presentation can be accessed through the Company's website at [ www.clda.com ].

About Clinical Data, Inc.

Clinical Data is a global biotechnology company unlocking the potential of molecular discovery, From Targeted Science to Better Healthcare^®. The Company's PGxHealth division is utilizing its biomarker intellectual property to develop and commercialize a broad pipeline of targeted therapeutics as well as pharmacogenetic tests that help predict drug safety and efficacy, thereby reducing health care costs. Its Cogenicsdivision provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. Please visit the Company's website at [ www.clda.com ] for more information.